IJCM_280A: A prospective study on safety and clinical efficacy of rabies biologicals in paediatric patients with category III animal exposure

Autor: Fotedar Nidhi, Ravish HS

Publikováno v: Indian Journal of Community Medicine, Vol 49, Iss 7, Pp 81-81 (2024)

Background: Rabies remains a significant public health concern worldwide, particularly among paediatric populations who are vulnerable to animal exposures. This prospective study aimed to assess the safety and clinical efficacy of rabies biologicals

Externí odkaz: https://doaj.org/article/c8b8635ebebd4f81bb1048e60a4cca6d

Safety of purified chick embryo cell rabies vaccine administered in previously vaccinated animal handlers working in a biological park

Autor: Anwith Hs, Nitu Kumari, Ravish Hs, M. P. Ramya

Publikováno v: International Journal of Advanced Community Medicine. 2:136-138

Background: Wild animal handlers are at continuous risk of exposure to rabies. They have to be protected against rabies by pre-exposure rabies vaccination and regular booster doses. Methodology: The study was conducted in a biological park in Karnata

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e30dffecea3617e1efe52ece0ecb634
https://doi.org/10.33545/comed.2019.v2.i2b.20

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.

Autor: Gogtay NJ; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra., Munshi R; Department of Clinical Pharmacology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra., Ashwath Narayana DH; Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bengaluru., Mahendra BJ; Department of Community Medicine, Mandya Institute of Medical Sciences, Karnataka., Kshirsagar V; Department of Preventive and Social Medicine (Community Medicine), B. J. Government Medical College and Sassoon General Hospitals., Gunale B; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India., Moore S; Rabies Laboratory, Kansas State University, Manhattan., Cheslock P; MassBiologics, University of Massachusetts Medical School, Boston., Thaker S; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra., Deshpande S; Department of Clinical Pharmacology, KEM Hospital and Seth G. S. Medical College, Mumbai, Maharashtra., Karande S; Department of Pediatrics, KEM Hospital and Seth G. S. Medical College., Kumbhar D; Department of Clinical Pharmacology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra., Ravish HS; Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bengaluru., Harish BR; Department of Community Medicine, Mandya Institute of Medical Sciences, Karnataka., Pisal SS; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India., Dhere R; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India., Parulekar V; DiagnoSearch Life Sciences Pvt Ltd, Thane, Maharashtra, India., Blackwelder WC; School of Medicine, University of Maryland-Baltimore., Molrine DC; MassBiologics, University of Massachusetts Medical School, Boston., Kulkarni PS; Serum Institute of India Pvt Ltd, Pune, Maharashtra, India.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2018 Jan 18; Vol. 66 (3), pp. 387-395.

Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.

Autor: Ravish HS; a Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Banashankari 2nd stage; Bangalore, India., Vijayashankar V, Madhusudana SN, Sudarshan MK, Narayana DH, Andanaiah G, Ashwin BY, Rachana AR, Shamanna M

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2014; Vol. 10 (8), pp. 2433-7.

Assessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans.

Autor: Ravish HS; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India., Sudarshan MK; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India., Madhusudana SN; Department of NeuroVirology; NIMHANS; Bangalore, India., Annadani RR; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India., Narayana DH; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India., Belludi AY; Department of NeuroVirology; NIMHANS; Bangalore, India., Anandaiah G; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India., Vijayashankar V; Department of Community Medicine; Kempegowda Institute of Medical Sciences (KIMS); Bangalore, India.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2014; Vol. 10 (5), pp. 1354-8. Date of Electronic Publication: 2014 Feb 28.